Ascendis Pharma A-S
Price & Volume
Stats
See more52W Range | $186.05-$282.15 |
Market Cap | $15B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $1B |
Revenue Growth (YoY) | 114.7% |
Gross Profit (12 Mos) | $955.8M |
Diluted EPS | $13.05 |
News
See moreYahoo Finance • 20 days ago
Ascendis Pharma (ASND) Authorizes $400M Share Buyback
Yahoo Finance • 22 days ago
Ascendis Pharma (ASND) Regains Exclusive Rights To Key TransCon Metabolic Programs
Yahoo Finance • 24 days ago
Ascendis Pharma (ASND) Will Regain Metabolic Drug Rights. Is Greater Ownership Worth the Cost?
Yahoo Finance • 26 days ago
Sector Update: Healthcare Stocks Fall Pre-Bell Tuesday
About
CEO | Mr. Jan Moller Mikkelsen |
CFO | Mr. Scott T. Smith |
Address | Tuborg Boulevard 12, Hellerup, Denmark, 2900 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1,189 |